Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies
| Date | 14th, Jul 2020 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19.